Mark Kawakami - 09 May 2025 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Reporting relationship: Chief Financial Officer
Issuer ticker: RKDA
Reported as of: 09 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 May 2025, 20:56:01 UTC
Prior SEC filing: 05 Feb 2025
Source filing: View source filing
Reporting owner signature: Mark Kawakami, by Attorney-in-fact, Solaeta Chan

Key filing fact

Mark Kawakami filed Form 4 for Arcadia Biosciences, Inc. (RKDA) on 12 May 2025.

Key facts

This page summarizes Mark Kawakami's Form 4 filing for Arcadia Biosciences, Inc. (RKDA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 12 May 2025, 20:56.

Change

Previous filing in this sequence was filed on 05 Feb 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002030709 Primary reporting owner

Kawakami Mark

Relationship: Chief Financial Officer
Address: C/O ARCADIA BIOSCIENCES, INC., 5950 SHERRY LANE, SUITE 215, DALLAS
Signature: Mark Kawakami, by Attorney-in-fact, Solaeta Chan
Signature date: 12 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RKDA transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +12,500
Change %: +58%
Price: $0.000000
Shares after: 33,987
Date: 09 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,500
Exercise price: $3.88
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options were granted on 5/9/2025 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.